Lipocine Inc. (NASDAQ: LPCN)
$6.91
N/A ( 0% ) 3.7K
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
Market Data
Open
$6.91
Previous close
$6.91
Volume
3.7K
Market cap
$37.11M
Day range
$6.94 - $7.10
52 week range
$2.31 - $11.79
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 25, 2024 |
8-k | 8K-related | 41 | Jun 10, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
8-k | 8K-related | 15 | Jun 05, 2024 |
8-k | 8K-related | 15 | Jun 03, 2024 |
10-q | Quarterly Reports | 68 | May 09, 2024 |